Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.hemonc.2015.04.005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cyclosporine-related brainstem atypical posterior reversible leukoencephalopathy syndrome following hematopoietic stem cell transplant.
Hematol Oncol Stem Cell Ther
March 2016
Department of Hematology and Cellular Therapy, Hospital University Establishment 1st November, Oran, Algeria.
Cyclosporine-related posterior reversible encephalopathy syndrome after heart transplantation: should we withdraw or reduce cyclosporine?: case reports.
Transplant Proc
March 2009
Heart Transplant Unit, Louis Pradel's Cardiovascular Hospital, Hospices civils Lyon, Lyon, France.
Cyclosporine (CsA) related encephalopathy has not been well documented after heart transplantation. We report 2 cases of posterior reversible encephalopathy syndrome (PRES). The first case was a 68-year-old woman who underwent heart transplantation and received immunosuppression with mycophenolate mofetil, prednisone, and CsA.
View Article and Find Full Text PDFClinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.
Eur J Haematol
August 2001
BMT-Unit, Brussels, Belgium.
Objectives: Severe neurotoxicity is a recognized complication of cyclosporin A (cyclosporine, CSA). Neuroimaging studies typically show reversible brain lesions, predominantly confined to the white matter. Our aim was to delineate clinical characteristics and to specify results of magnetic resonance imaging (MRI) and computerised tomography (CT) scan findings.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!